- Home
- LYTS vs ATXS Comparison
LYTS vs ATXS Comparison
Compare LYTS & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYTS
- ATXS
- Stock Information
- Founded
- LYTS 1976
- ATXS 2008
- Country
- LYTS United States
- ATXS United States
- Employees
- LYTS N/A
- ATXS N/A
- Industry
- LYTS Building Products
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- LYTS Consumer Discretionary
- ATXS Health Care
- Exchange
- LYTS Nasdaq
- ATXS Nasdaq
- Market Cap
- LYTS 700.9M
- ATXS 676.1M
- IPO Year
- LYTS N/A
- ATXS 2015
- Fundamental
- Price
- LYTS $23.66
- ATXS $12.46
- Analyst Decision
- LYTS Strong Buy
- ATXS Buy
- Analyst Count
- LYTS 2
- ATXS 7
- Target Price
- LYTS $27.50
- ATXS $30.00
- AVG Volume (30 Days)
- LYTS 135.3K
- ATXS 4.1M
- Earning Date
- LYTS 11-06-2025
- ATXS 11-12-2025
- Dividend Yield
- LYTS 0.84%
- ATXS N/A
- EPS Growth
- LYTS N/A
- ATXS N/A
- EPS
- LYTS 0.79
- ATXS N/A
- Revenue
- LYTS $573,377,000.00
- ATXS N/A
- Revenue This Year
- LYTS $5.91
- ATXS N/A
- Revenue Next Year
- LYTS $8.03
- ATXS N/A
- P/E Ratio
- LYTS $29.96
- ATXS N/A
- Revenue Growth
- LYTS 22.09
- ATXS N/A
- 52 Week Low
- LYTS $13.77
- ATXS $3.56
- 52 Week High
- LYTS $25.50
- ATXS $12.55
- Technical
- Relative Strength Index (RSI)
- LYTS 60.04
- ATXS 84.72
- Support Level
- LYTS $22.22
- ATXS $11.83
- Resistance Level
- LYTS $23.48
- ATXS $12.16
- Average True Range (ATR)
- LYTS 0.71
- ATXS 0.36
- MACD
- LYTS 0.09
- ATXS 0.26
- Stochastic Oscillator
- LYTS 88.19
- ATXS 97.97
About LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.